Revenue Breakdown
Composition ()
No data
Revenue Streams
Agape ATP Corp (ATPC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Others – Products for the provision of complementary health therapies, accounting for 60.1% of total sales, equivalent to $222.64K. Other significant revenue streams include Skin care and healthcare products and Health and wellness services. Understanding this composition is critical for investors evaluating how ATPC navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Agape ATP Corp maintains a gross margin of 64.52%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -162.26%, while the net margin is -160.65%. These profitability ratios, combined with a Return on Equity (ROE) of -21.20%, provide a clear picture of how effectively ATPC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ATPC competes directly with industry leaders such as PAVS and SCNI. With a market capitalization of $1.89M, it holds a significant position in the sector. When comparing efficiency, ATPC's gross margin of 64.52% stands against PAVS's 19.98% and SCNI's -164.29%. Such benchmarking helps identify whether Agape ATP Corp is trading at a premium or discount relative to its financial performance.
